Botanical species · safety record

Monarda punctata

The EFSA Compendium of Botanicals holds 1 constituent measurement and 1 adverse-effect record for Monarda punctata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Monarda punctata L.

1Constituent measurements
1Safety records
2Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Quinones1

Plant parts

  • Flowering top1
  • Live plants1

Preparations

  • Essential oil1
  • Solvent extraction1

Effect types

  • Digestive1

Target tissues

  • Digestive: pancreas1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
QuinonesFlowering topEssential oilUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestive: pancreasLive plantsSolvent extractionIn vitroResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Yamada, Keiko., Murata, Toshihiro., Kobayashi, Kyoko., Miyase, Toshio., Yoshizaki, Fumihiko. A lipase inhibitor monoterpene and monoterpene glycosides from Monarda punctata. PHYTOCHEMISTRY, 2010, vol. 71, no. 16, p. 1884-1891. DOI
  2. Phillips, M. An unusual oil from Monarda punctata. Journal of the american pharmaceutical association, None, p. 177-179.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue